Danaher Corporation-backed Leica Biotechnology to invest in Indica Labs.

Danaher Corporation-backed Leica Biotechnology, an anatomic and digital pathology solutions, agreed to invest in Indica Labs, an AI-powered digital pathology software. Financial terms were not disclosed. "This is a truly groundbreaking partnership designed to accelerate the advent of next-generation AI-enabled solutions in cancer diagnostics. Leica Biosystems is proud to partner with Indica Labs to develop and deliver a world-class computational pathology solution to customers and their patients. The opportunities for innovation are endless with our Aperio GT 450 DX and Indica Labs' HALO software for image management," Gustavo Perez-Fernandez, Leica Biosystems President.